Metronidazole for Clostridium difficile-Associated Disease: Is It Okay for Mom?
Open Access
- 1 June 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (11), 1598-1600
- https://doi.org/10.1086/430317
Abstract
Potential conflicts of interest. D.N.G. holds patents for the treatment and prevention of Clostridium difficile-associated disease and is a consultant for and/oKeywords
This publication has 7 references indexed in Scilit:
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004
- ASHP Therapeutic Position Statement on the Preferential Use of Metronidazole for the Treatment of Clostridium difficile-Associated DiseaseAmerican Journal of Health-System Pharmacy, 1998
- Comparison of Vancomycin, Teicoplanin, Metronidazole, and Fusidic Acid for the Treatment of Clostridium difficile--Associated DiarrheaClinical Infectious Diseases, 1996
- Recommendations for Preventing the Spread of Vancomycin ResistanceInfection Control & Hospital Epidemiology, 1995
- PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITISThe Lancet, 1983